Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01057433 |
Recruitment Status :
Completed
First Posted : January 27, 2010
Results First Posted : August 13, 2012
Last Update Posted : August 13, 2012
|
Sponsor:
Kowa Research Institute, Inc.
Information provided by (Responsible Party):
Kowa Research Institute, Inc.
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Non-Randomized; Intervention Model: Single Group Assignment; Masking: None (Open Label) |
Condition |
Healthy Volunteers |
Interventions |
Drug: Pitavastatin (NK-104) Drug: Lopinavir/ritonavir |
Enrollment | 24 |
Participant Flow
Baseline Characteristics
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Principal Investigators are NOT employed by the organization sponsoring the study.
There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts
the PI's rights to discuss or publish trial results after the trial is completed.
May not publish.
Results Point of Contact
Name/Title:
Roger Morgan, MD, FACS
Organization:
Kowa Research Institute, Inc.
Phone:
919-433-1600
EMail:
RMorgan@KowaUS.com
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Kowa Research Institute, Inc. |
ClinicalTrials.gov Identifier: | NCT01057433 History of Changes |
Other Study ID Numbers: |
NK-104-4.02US |
First Submitted: | January 25, 2010 |
First Posted: | January 27, 2010 |
Results First Submitted: | March 23, 2012 |
Results First Posted: | August 13, 2012 |
Last Update Posted: | August 13, 2012 |